A
Asklepios BioPharmaceutical
Research Triangle Park, United States
Founded 2001
Nanomedicine Gene Therapy Delivery Protein Nanoparticles Regenerative Medicine Nanobiosensors Nano Research
About
Gene therapy company developing AAV-based treatments for genetic diseases
Company Details
- Type
- commercial
- Employees
- 600+
- Funding
- Acquired by Bayer
Key Products
- Pro10
- AAV Manufacturing
- Pompe Gene Therapy